3Sun P,Dwyer KM,Merz CN,et al.Blood pressure,LDL cholesterol,and intima-media thickness:a test of the "response to injury" hypothesis of atherosclerosis[J].Arterioscler Thromb Vasc Biol,2000,20(8):2005-2010.
4Lee TH,Hsu WC,Chen CJ,et al.Etiologic study of young ischemic stroke in Taiwan[J].Stroke,2002,33(8):1950-1955.
2Pickup J,Williams G.Textbook of diabetes.In:Giardino I,Brownlee M.The biochemical basis of microvascular disease.Blackwell of Science Ltd,1997.42
3American Diabetes Association.Implication of the United Kingdom prospective diabetes study.Diabetes Care,1998,21(12):2180-2184
4C ardo E, Monros E, Colome C, et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and Vitamin status [J] .J Child Neurol,2000,15(5) :295-298.
6Hankey GJ, Eikelboom JW. Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications[J]. CNS Drugs,2001,15(6):437-443.
7Frosst P, Blotm HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase[ J]. Nat Genet, 1995,10(1): 111-113.
8Pezzini A, Del Zotto E, Archetti S, et al. Hasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke[J]. Stroke,2002,33(3) :664-669.
9Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocysteine and ischemic stroke due to large-and small-artery disease but not other etiologic subtypes of ischemic stroke[J] .Stroke,2000,31(5): 1069-1075.
10You JH, Choi GD, Kang SS. Pathogenicity of thennolabile methylenetetrahydrofolate reductnse for vascular dementia[J]. Arterioscler-Thromb-Vasc-Biol,2000,20(8): 1921-1925.
